MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved ...

Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...

A retrospective study suggested that use of the dual GIP/GLP-1 drug tirzepatide was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 ...

“The observed ocular benefits may be attributable to tirzepatide’s superior metabolic effects, along with potential neuroprotective properties mediated by” the drug’s activation of both ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low ...